MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

A CURE For The Ordinary Health Care ETF

TedTed
in The Bullpen
FYI: Although the usual caveat of leveraged ETFs not being buy and hold instruments certainly applies to CURE, the ETF’s one-year gain of 87% is hard to ignore. Due to the effects of daily rebalancing, some leveraged ETFs are famous for significantly lagging their underlying indexes and their non-leveraged equivalents. That has not been the case with CURE. Over the past year, XLV is up 25%, meaning CURE has actually better than triple the returns of its non-leveraged counterpart. [Anonymous Leveraged Health Care ETFs]
Regards,
Ted
http://www.etftrends.com/2015/02/a-cure-for-the-ordinary-health-care-etf/

M* Snapshot Of CURE: http://etfs.morningstar.com/quote?t=CURE&region=usa&culture=en-US
Sign In or Register to comment.